Form 4: Teladoc Health Executive Adam C. Vandervoort Reports Acquisition of Restricted Stock Units

Adam C. Vandervoort, Chief Legal Officer and Secretary of Teladoc Health, reports the acquisition of 64,200 restricted stock units (RSUs) on March 19, 2024.

Summary

• Adam C. Vandervoort, the Chief Legal Officer and Secretary of Teladoc Health, Inc., filed a Form 4 with the SEC.
• The filing reports the acquisition of 64,200 restricted stock units (RSUs) on March 19, 2024.
• Each RSU represents a contingent right to receive one share of Teladoc Health common stock.
• The RSUs vest over time, with one-third vesting on the first anniversary of the grant date and the remainder vesting in eight substantially equal quarterly installments starting June 1, 2025.
• Following the reported transaction, Vandervoort directly owns 64,200 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing related to executive compensation. The acquisition of RSUs can be seen as a positive sign of confidence, but it's not a major event.

Positives

• The acquisition of RSUs by a key executive could be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The vesting schedule of the RSUs suggests a multi-year commitment from the executive.

Industry Context

Executive compensation in the form of stock options and RSUs is a common practice in the healthcare technology industry to align management's interests with those of shareholders.

Comparison to Industry Standards

• Stock-based compensation is a standard practice among publicly traded companies, particularly in the tech and healthcare sectors.
• Companies like Amwell (AMWL) and Livongo (prior to its acquisition by Teladoc) also utilized RSUs as part of their executive compensation packages.
• The vesting schedule of one-third on the first anniversary and the remainder in quarterly installments is a fairly typical vesting arrangement.

Stakeholder Impact

• The vesting of RSUs will gradually increase the executive's stake in the company, aligning their interests with those of shareholders.

Key Dates